CCM
BPMC
Cadian Capital Management’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,459,431
| Closed | -$96.2M | – | 33 |
|
|
2022
Q3 | $96.2M | Sell |
1,459,431
-561,198
| -28% | -$37M | 5.62% | 6 |
|
|
2022
Q2 | $102M | Buy |
2,020,629
+99,282
| +5% | +$5.01M | 6.89% | 4 |
|
|
2022
Q1 | $123M | Buy |
1,921,347
+1,470,690
| +326% | +$93.9M | 6.13% | 5 |
|
|
2021
Q4 | $48.3M | Sell |
450,657
-601,546
| -57% | -$64.4M | 2.65% | 14 |
|
|
2021
Q3 | $108M | Sell |
1,052,203
-269,110
| -20% | -$27.7M | 4.08% | 7 |
|
|
2021
Q2 | $116M | Buy |
1,321,313
+407,611
| +45% | +$35.9M | 5.16% | 7 |
|
|
2021
Q1 | $88.8M | Sell |
913,702
-145,748
| -14% | -$14.2M | 3.29% | 12 |
|
|
2020
Q4 | $119M | Sell |
1,059,450
-1,627,406
| -61% | -$183M | 3.05% | 14 |
|
|
2020
Q3 | $249M | Buy |
2,686,856
+1,488,867
| +124% | +$138M | 8.11% | 3 |
|
|
2020
Q2 | $93.4M | Sell |
1,197,989
-28,107
| -2% | -$2.19M | 3.88% | 12 |
|
|
2020
Q1 | $71.7M | Sell |
1,226,096
-741,942
| -38% | -$43.4M | 3.53% | 13 |
|
|
2019
Q4 | $158M | Buy |
1,968,038
+549,334
| +39% | +$44M | 6.96% | 3 |
|
|
2019
Q3 | $104M | Buy |
1,418,704
+895,443
| +171% | +$65.8M | 4.96% | 7 |
|
|
2019
Q2 | $49.4M | Buy |
523,261
+323,261
| +162% | +$30.5M | 2.23% | 18 |
|
|
2019
Q1 | $16M | Buy |
+200,000
| New | +$16M | 0.62% | 26 |
|
|
2017
Q4 | – | Sell |
-313,965
| Closed | -$21.9M | – | 27 |
|
|
2017
Q3 | $21.9M | Sell |
313,965
-143,137
| -31% | -$9.97M | 1.02% | 27 |
|
|
2017
Q2 | $23.2M | Buy |
457,102
+282,202
| +161% | +$14.3M | 1.13% | 27 |
|
|
2017
Q1 | $6.99M | Buy |
+174,900
| New | +$6.99M | 0.33% | 39 |
|